Telo Genomics Corp. (TELO.V)

CAD 0.12

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue - - - - - -
Cost of Revenue 39.53 Thousand 33.11 Thousand 56.95 Thousand 62.22 Thousand 64.71 Thousand 82.9 Thousand
Gross Profit -39.53 Thousand -33.11 Thousand -56.95 Thousand -62.22 Thousand -64.71 Thousand -82.9 Thousand
Operating Expenses 2.67 Million 2.82 Million 2.11 Million 1.25 Million 1.31 Million 1.05 Million
Selling, General and Administrative Expenses 1.35 Million 1.45 Million 986.62 Thousand 653.29 Thousand 946.11 Thousand 856.74 Thousand
Research and Development Expenses 1.32 Million 1.36 Million 1.12 Million 603.9 Thousand 364.74 Thousand 196.77 Thousand
Other Expenses - - - 183.48 Thousand 95.69 Thousand -
Cost and Expenses 2.71 Million 2.82 Million 2.11 Million 1.25 Million 1.31 Million 1.05 Million
Operating Income -2.71 Million -2.82 Million -2.11 Million -1.07 Million -1.21 Million -1.05 Million
Interest Expense 4614.00 5206.00 5390.00 - 26.53 Thousand 20.67 Thousand
Income Tax Expense 10 Thousand -5202.00 -5394.00 183.48 Thousand 122.23 Thousand -78.23 Thousand
Earnings before Tax -2.71 Million -2.82 Million -2.11 Million -1.06 Million -1.24 Million -1.07 Million
Net Income -2.71 Million -2.82 Million -2.11 Million -1.06 Million -1.24 Million -1.07 Million
Earnings Per Share Basic -0.04 -0.05 -0.04 -0.02 -0.04 -0.08
Earnings Per Share Diluted -0.04 -0.05 -0.04 -0.02 -0.04 -0.08
Weighted Average Shares Outstanding 71.38 Million 60.15 Million 58.66 Million 46.88 Million 29.92 Million 13.22 Million
Weighted Average Shares Outstanding (Diluted) 71.38 Million 60.15 Million 58.66 Million 46.88 Million 29.92 Million 13.22 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -2.66 Million -2.78 Million -2.04 Million -1 Million -1.15 Million -970.61 Thousand
Earnings Before Tax Margin - - - - - -

Income Statement Charts